Project Grant R21AG091261
Award Date
1/1/25
Completion Date
12/31/27
Dollars Obligated
$447K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
This $2,365,042 Project Grant award from the National Institute on Aging's Aging Research Program (CFDA 93.866) supports research to better understand the biological underpinnings of Alzheimer's disease and related dementias (ADRD). The primary objectives are to leverage cross-national data from the U.S. and India to evaluate associations between neurodegenerative biomarkers, cognitive outcomes, and socioeconomic factors. Key project activities include developing harmonized measures for...
This $307,000 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support a study to identify the earliest memory changes associated with preclinical Alzheimer's disease (AD). The University of Arizona will conduct this research over a 2-year period from September 2024 to August 2026. The key objectives are to use advanced behavioral and neuroimaging techniques to detect subtle changes in memory precision that can differentiate healthy aging...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $12,847,914 to Emory University to conduct a comprehensive study on the Alzheimer's disease (AD) and Alzheimer's-related dementias (ADRD) continuum in middle-aged South Asians in India. The study aims to: Perform multimodal AD/ADRD phenotyping and genetic characterization across the disease continuum; Investigate modifiable socio-behavioral and vascular/metabolic risk factors...
This is a $2,451,044 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to The Trustees of Columbia University in the City of New York. The grant will fund a project titled "Engaging Aging Minds: Labor Force Participation, Stimulating Activities, and Cognitive Aging Across Diverse International Settings." The project will investigate the impact of labor force participation and stimulating activities in middle and later life on cognitive aging...
This $1,205,827 Project Grant, awarded by the National Institute on Aging (CFDA 93.866 - Aging Research), will examine the role of environmental exposures as a risk factor for Alzheimer's disease (AD) among non-Hispanic Whites, African Americans, and Mexican Americans. The project will utilize blood samples from 3,000 participants in the ongoing Health & Aging Brain Study - Health Disparities Study to investigate the "exposome" and its impact on AD development within these...
The National Institute on Aging (NIH) awarded a $460,548 Project Grant under CFDA 93.866 (Aging Research) to Yale University to develop neuroimaging methodologies for early detection of Alzheimer's disease (AD) through biomarker imaging. The 2-year project (9/30/2024 - 8/31/2026) aims to longitudinally characterize functional connectivity alterations in olfactory networks, mitochondrial energy metabolism, and memory/smell abilities in a transgenic AD rat model using in vivo multi-modal MRI/MRS...
This Project Grant award for $353,391.00, funded by the National Institute on Aging (CFDA 93.866 - Aging Research), aims to validate a digital tool called the Personal Learning Curve (PLC) for early detection and sensitive tracking of cognitive changes related to Alzheimer's disease (AD) in a representative sample of older adults at risk for AD and related dementias. The project will recruit 300 participants who have completed the active phase of the U.S. POINTER clinical trial on multi-domain...
This federal Project Grant award of $2,288,528, provided by the National Institute on Aging under CFDA 93.866 - Aging Research, supports a study on mild cognitive impairment (MCI) and Alzheimer's disease and related dementias (ADRD) across the U.S., Mexico, and India. The key objectives are to: 1) harmonize MCI and dementia classifications cross-nationally and compare the longitudinal prognosis of MCI; 2) investigate the unique and shared sociodemographic, lifestyle, health, and biological...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $420,947 to develop a longitudinal study on aging in Guatemala, with a focus on Alzheimer's disease and related dementias. The key products and services to be delivered under this 2-year award include: Translating and adapting aging survey modules, including cognition and dementia assessments, to Spanish and Mayan languages for use in Guatemala. New modules will also be developed on language...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $147,656 to Emory University to develop the first human locus coeruleus (LC) organoid model to study the role of the LC in the earliest stages of Alzheimer's disease (AD). The key products and services to be delivered include: Validating the structure and function of the LC organoids by comparing them to human and rodent LC neurons. 2) Combining the LC organoids with cortical organoids to define...